Rehab and physical therapy devices startup Hollywog landed a pair of FDA nods for its wireless back pain therapy devices, the WiTouch and the WiTouch Pro.
The devices use transcutaneous electrical nerve stimulation, a process in which electrical signals are transmitted through the skin to stimulate nerve or muscle fibers, to suppress pain signals before they they reach the brain and ramp up the body’s production of pain-relieving endorphins, according to the company’s website.
Neuros recently received an investigational device exemption from the FDA to evaluate its chronic pain management system, the electrical nerve block, for use in amputee patients to manage pain in the residual limb.
The memo detailed adverse events possibly associated with improper use of its Granuflo dialysis concentrate, including a possible 5-fold increase in heart-attack risk associated with the compound.
MASSDEVICE ON CALL — Health care spending grew only 3.8% in 2009 and 3.9% in 2010, the smallest spending increase in 50 years.
The rate of growth in the health care sector has slowed every year since 2002, but the rates in 2009 and 2010 were especially pronounced, according to the Centers for Medicare & Medicaid Services national health expenditure report.
Update: Saturday, Dec. 10, 2011 – The headline for this story mistakenly reported that the AdaptiveStim system treats DBS pain. It is for treatment of chronic pain.
Medtronic (NYSE:MDT) unveiled clinical data in support of its recently cleared AdaptiveStim pain management implant with RestoreSensor at the North American Neuromodulation Society meeting this week.
MASSDEVICE ON CALL — House Republicans began circulating a proposal to come up with the $38 billion needed to pay for an impending cut in Medicare payments to doctors, Healthwatch reported.
The proposal aims to pay for the payments for two years by increasing rates for high-income seniors on Medicare, repealing unspecified parts of health care reform laws and means-testing.